Review




Structured Review

Mimetics incretin mimetics
Incretin Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+mimetics/incretin+mimetics/pm42321077-49-7-8
Average 86 stars, based on 1 article reviews
incretin mimetics - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.

Activation Assay:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.

Migration:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.

Inhibition:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.

In Vitro:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.

In Vivo:

Article Title: Metabolic reprogramming by caloric restriction enhances acute phase virological control and reduces chronic inflammation in SIV-infected rhesus macaques
Article Snippet: Short-term CR, or reducing caloric intake pharmacologically by mimicking satiety with incretin mimetics , may represent a more clinically relevant extension to this study.

Article Title: Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests
Article Snippet: Incretin mimetics , 1,651 (8.82%) , 1,057 (7.69%) , 207 (12.68%) , 387 (11.64%).

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 3 GLP-1 RAs do not appear to change the percentage lean body mass, 27 suggesting that any loss in muscle is commensurate with loss of fat and reduced weightbearing needs.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Incretin Mimetics in Cancer and Cardiovascular Disease F E B R U A R Y 2 0 2 6 : 1 – 1 6 4 78% increase in the risk for developing hypertension 36 and may benefit from the salutary effects of incretin mimetics on weight gain and blood pressure concurrent with their cancer treatments.

Article Title: Incretin Mimetics in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review.
Article Snippet: 1 , 2 0 2 6 Leong et al F E B R U A R Y 2 0 2 6 : 1 – 1 6 Incretin Mimetics in Cancer and Cardiovascular Disease 15 a systematic review and meta-analysis.



Similar Products

86
Mimetics incretin mimetics
Incretin Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+mimetics/incretin+mimetics/pm42321077-49-7-8
Average 86 stars, based on 1 article reviews
incretin mimetics - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Mimetics incretin mimetics on cancer signaling
Incretin Mimetics On Cancer Signaling, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+mimetics/incretin+mimetics/pm41705747-159-4-5
Average 86 stars, based on 1 article reviews
incretin mimetics on cancer signaling - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Mimetics implicate incretin mimetics in cancer pathways
Implicate Incretin Mimetics In Cancer Pathways, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+mimetics/incretin+mimetics/pm41705747-204-1-3
Average 86 stars, based on 1 article reviews
implicate incretin mimetics in cancer pathways - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results